Global Cardio Oncology Registry
NCT05598879 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-05-12
Summary
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
Conditions
- Breast Cancer
- Hematologic Malignancy
- Immune Checkpoint Inhibitor-Related Myocarditis
- Cardiotoxicity
- Cardiovascular Diseases
Interventions
- OTHER
-
anonymized data collection during programmed surveillance clinical follow up
anonymized data entry of demographic, clinical, imaging, laboratory, cancer treatment, and cardiovascular events into a RedCap Cloud platform
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Diego Sadler, MD FACC · The Cleveland Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2029-07-01
- Completion
- 2029-07-01
Countries
- United States
Study Locations
More Related Trials
-
Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome
NCT06441942 ·Status: RECRUITING
-
Prospective Coronary Heart Disease Cohort
NCT05699629 ·Status: RECRUITING
-
Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.
NCT00769574 ·Status: COMPLETED ·Phase: NA
-
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
NCT05992337 ·Status: UNKNOWN
-
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
NCT05851053 ·Status: RECRUITING
-
International Takotsubo Registry (InterTAK Registry)
NCT01947621 ·Status: UNKNOWN
-
Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
NCT07041827 ·Status: COMPLETED
-
Sex Difference of Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease
NCT06076551 ·Status: RECRUITING
-
Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors
NCT02485626 ·Status: UNKNOWN
-
Cardiac Biomarkers and Analytical Methods
NCT05781724 ·Status: COMPLETED
-
To Develop and Introduce Into Polyclinic Practice a Register of Patients with Experience of Myocardial Infarction and Acute Cerebrovascular Disease
NCT06815913 ·Status: ACTIVE_NOT_RECRUITING
-
THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES
NCT02141750 ·Status: COMPLETED
-
Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease
NCT05337319 ·Status: RECRUITING
-
Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19
NCT02490969 ·Status: COMPLETED
-
CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction
NCT02385682 ·Status: COMPLETED
-
MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR
NCT06139094 ·Status: COMPLETED
-
Early Detection of Imaging-derived Subclinical Cardiac Injuries
NCT03575650 ·Status: RECRUITING
-
Symptoms of Acute Coronary Syndrome in Medical Regulation
NCT05902130 ·Status: COMPLETED
-
Cardiology Research Dubrava Prospective Registry
NCT06090591 ·Status: RECRUITING
-
Coronary Microvascular Dysfunction in Chronic Kidney Disease
NCT04014127 ·Status: UNKNOWN
-
Artificial Intelligence With DEep Learning on COROnary Microvascular Disease
NCT04598997 ·Status: RECRUITING
-
The Prognosis of Acute Myocardial Infarction
NCT02737956 ·Status: COMPLETED
-
Women's Assessed Cardiovascular Evaluation With MCG
NCT04739280 ·Status: COMPLETED
-
Cardiology Biobank Registry
NCT00378924 ·Status: RECRUITING
-
PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy
NCT04538950 ·Status: COMPLETED ·Phase: PHASE1/PHASE2